RareResearch.AI
← Back to atlas

K191N

Category 3/4 — Most DruggableUncertain significanceCytoplasmic · predictedSource card
LysineAsparagine at position 191 · N-terminal cytoplasmic (intrinsically disordered) · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference
Wild-type K191 — hydrogen bond to N188
Fullscreen ↗
DynaMut2 mutant · K191N
Mutant N191 — hydrophobic contact to W185 lost
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

0 lost0 gained4 preserved
Interaction typeWild-type partnerMutant partnerStatus
Hydrogen bondN188N188Preserved
Polar contactN188N188Preserved
Polar contactP189P189Preserved
HydrophobicW185W185Preserved

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
-0.23kcal/mol
Destabilising — mild
AlphaMissense
0.803
likely pathogenic
AlphaFold pLDDT
83
model confidence
Schema
Cat 3/4
Category 3/4 — Most Druggable

Clinical Evidence

ClinVar classificationUncertain significance
Review statuscriteria provided, single submitter
Associated conditions
Population frequency (gnomAD v4)Absent from gnomAD v4
cDNA changec.573G>T
ClinVar accessionVCV002872798
Last evaluated2023/04/24 00:00

Not observed in ~730k individuals — consistent with a rare allele (ACMG PM2_supporting).

Full Variant Card

WFS1 Wolframin — K191N Variant Card

Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill

Lysine → Asparagine at position 191. N-terminal cytoplasmic (intrinsically disordered). ClinVar Uncertain significance, AlphaMissense 0.803, DynaMut2 ΔΔG -0.23 kcal/mol (destabilising).


Identity

FieldValue
VariantK191N (p.Lysine191Asparagine)
DNA changec.573G>T
Gene · ProteinWFS1 · Wolframin (890 aa)
UniProtO76024 · WFS1_HUMAN
ClinVar accessionVCV002872798
Amino acid changeLysine (K) → Asparagine (N)

Structural Context

FieldValue
AlphaFold modelAF-O76024-F1, v6
pLDDT at residue 19182.50 — well-folded
DomainN-terminal cytoplasmic (intrinsically disordered)
Position contextN-terminal cytoplasmic (intrinsically disordered)
IDR flagNo — pLDDT above 50 threshold

UniProt features at this position:

(none catalogued)

Position 191 sits in N-terminal cytoplasmic (intrinsically disordered). The wild-type residue is positively charged (lysine — primary amine); the mutant is polar amide (asparagine — H-bond donor/acceptor). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.


Computational Predictions

AlphaMissense

FieldValue
am_pathogenicity0.8028
am_classlikely pathogenic
InterpretationLikely pathogenic (threshold 0.564)

DynaMut2

FieldValue
ΔΔG (kcal/mol)-0.23 (Destabilising)
Job ID178092116278
Result URLhttps://biosig.lab.uq.edu.au/dynamut2/results_prediction/178092116278

Clinical Evidence

FieldValue
ClassificationUncertain significance
Review statuscriteria provided, single submitter
Last evaluated2023/04/24 00:00
InheritanceInheritance pattern not specified in ClinVar entry; WFS1 has both AD and AR presentations.
WFS1 variant landscapeK191N is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar)

(no conditions catalogued)


Research Path Decision Tree

ΔΔG < 2  + binding site affected   →  CATEGORY 3 — docking experiments
ΔΔG 2–4                            →  CATEGORY 2 — pharmacological chaperones
ΔΔG > 4                            →  CATEGORY 1 — gene therapy
pLDDT < 50                         →  CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit  →  CATEGORY 4 — site-specific docking

Final Schema Categorization

Category 3/4 — Most Druggable

<strong>Category 3/4 — Most Druggable</strong><br/><br/>|ΔΔG|=0.23 < 2 kcal/mol (fold intact) + AlphaMissense 0.803 confirms functional impact. Specific local contacts disrupted — priority for docking and pharmacological chaperone screening.

Why this card matters. Wolframin's fold survives this substitution (|ΔΔG|=0.23 kcal/mol). The pathogenic signal is real — AlphaMissense places it at 0.803. Protein still folds, but a specific local site is broken. Pharmacological chaperones and small-molecule binders are the rational therapeutic vector.


Files in this folder

  • AF-O76024-F1-model_v6.pdb — AlphaFold structure
  • K191N_molstar_viewer.html — interactive 3D viewer (auto-highlights position 191 with ball-and-stick + neighbors within 5Å)
  • K191N_variant_card.md — this card (source of truth)
  • K191N_variant_card.html — styled printable card
  • K191N_dynamut2_summary.html — clean offline DynaMut2 result card
  • dynamut2_result.json — structured result data
  • dynamut2_result_page.html — local snapshot of the Biosig result page (asset URLs absolutized)
  • K191N_wildtype_interactions.pse / K191N_mutant_interactions.pse — PyMOL sessions

Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the K191N PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download K191N PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.